UiPath, Inc. (PATH) › Analysis

UiPath, Inc. (PATH) stock analysis, February 4, 2026: No. 1 AI benchmark, but PATH hits new YTD low at $12.23

Published February 4, 2026 · PATH chart, levels and live analysis

Key Updates

UiPath shares declined 5.08% to $12.23 since the last report, extending the downward trajectory and establishing a new YTD low. The stock has now fallen 25.38% year-to-date and 23.71% over the past month, breaking through the $12.59 support level identified in the previous analysis. Despite achieving the No. 1 ranking on the OSWorld-Verified benchmark for agentic automation with its Screen Agent powered by Claude Opus 4.5, the market continues to pressure the stock amid broader sector weakness. The persistent selling pressure suggests investors remain focused on valuation concerns and competitive dynamics rather than technical achievements, with the stock now trading at multi-quarter lows despite positive industry growth forecasts projecting the RPA market to reach $20.79 billion by 2032.

Current Trend

UiPath is in a severe downtrend with accelerating momentum. The stock has declined 25.38% YTD and 23.71% over the past month, with the recent 5.08% drop breaking below the $12.59 support level that briefly held on January 31st. The $13.38 level, which served as support in late January, has now become resistance. The 5-day decline of 13.32% indicates intensifying selling pressure, while the modest 7.85% gain over six months has been entirely erased by recent weakness. The stock is trading at new multi-quarter lows with no clear technical support visible until the $11-12 zone. The breakdown below $12.59 on deteriorating volume characteristics suggests capitulation among remaining bulls, with the next meaningful support potentially in the $10-11 range based on historical trading patterns.

Investment Thesis

The investment thesis for UiPath centers on its leadership position in the rapidly expanding agentic automation market, where the company has demonstrated technical superiority through benchmark achievements and is positioned to capture significant share of the RPA market projected to grow at 28.47% CAGR to $20.79 billion by 2032. UiPath's competitive advantage lies in its AI-augmented automation platform that commands 30-40% higher enterprise deal values compared to standalone tool providers, as organizations transition from task-level automation to strategic execution capabilities. The company's Screen Agent technology, now ranked No. 1 on the OSWorld-Verified benchmark, validates its technical leadership in deploying AI agents across 369 computer tasks involving web, desktop, and multi-application workflows. However, the thesis faces challenges from intensifying competition as Microsoft, IBM, Automation Anywhere, and emerging players like Rimini Street introduce alternative solutions that promise faster ROI and lower implementation costs. The market's current valuation suggests concerns about UiPath's ability to maintain pricing power and market share as enterprises increasingly evaluate cost-effective alternatives, particularly as competitors position AI-driven solutions that can deliver ROI in weeks rather than months.

Thesis Status

The investment thesis is under significant pressure despite positive industry fundamentals and technical validation. While UiPath achieved the No. 1 ranking on the OSWorld-Verified benchmark, demonstrating clear technical superiority over competitors, the stock's 25.38% YTD decline indicates the market is discounting this achievement amid valuation concerns and competitive threats. The 28.47% CAGR projected for the RPA market through 2032 supports the long-term growth narrative, yet UiPath's inability to translate industry tailwinds and technical leadership into positive stock performance suggests investors are questioning the company's ability to monetize its market position effectively. The emergence of alternative solutions from Rimini Street claiming 50-60% faster approval turnarounds and Microsoft's expanding presence in enterprise automation creates meaningful competitive pressure on UiPath's premium pricing model. The thesis remains intact from a market opportunity perspective, but execution concerns and valuation compression are overwhelming positive catalysts. The disconnect between technical achievements and stock performance indicates investors require evidence of accelerating revenue growth, expanding margins, or market share gains to validate the premium valuation historically commanded by the company.

Key Drivers

UiPath's technical leadership was validated through its No. 1 ranking on the OSWorld-Verified benchmark, demonstrating superiority in agentic automation across 369 enterprise tasks. The broader RPA market opportunity remains robust, with industry projections showing growth from $3.60 billion in 2025 to $20.79 billion by 2032 at a 28.47% CAGR, driven by enterprises deploying RPA at scale to achieve 25-35% operational cost reductions. However, competitive pressures are intensifying as Rimini Street launched 20 Agentic UX Solutions claiming 50-60% faster approval turnarounds and positioning as a cost-effective alternative to traditional automation platforms. The market is witnessing consolidation around platform leaders including UiPath, Microsoft, IBM, and Automation Anywhere, with platform-centric vendors commanding 30-40% higher enterprise deal values. Competitive dynamics are further complicated by adjacent players like Planview achieving 60% adoption of its AI solution within three months and demonstrating rapid enterprise acceptance of AI-driven workflow optimization tools.

Technical Analysis

UiPath has broken down through critical support levels, establishing new multi-quarter lows at $12.23. The stock violated the $12.59 support identified in the previous report and is now trading 25.38% below its YTD starting level with no clear support until the $11-12 zone. The 13.32% decline over five days represents acceleration in selling momentum, while the one-month loss of 23.71% indicates sustained distribution. The modest 0.66% daily gain provides no meaningful reversal signal given the magnitude of recent declines. Key resistance now exists at $12.59 (previous support), $13.38 (late January support turned resistance), and $14.20 (mid-January level). The six-month gain of 7.85% has been completely erased by the recent selloff, suggesting the stock is in a primary downtrend. Volume characteristics during the decline suggest institutional selling rather than retail capitulation. The breakdown below $12.59 on a closing basis confirms the bearish technical structure, with the next meaningful support zone potentially in the $10-11 range based on historical volatility patterns. The stock requires stabilization above $13.00 and reclamation of the $13.38 level to signal any potential trend reversal.

Bull Case

Bear Case

Get a message when the PATH picture changes — the agent team watches the levels and the news for you.Create a free account

More PATH analyses